Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Journal for ImmunoTherapy of Cancer

Figure 3

From: MAGE-specific T cells detected directly ex-vivo correlate with complete remission in metastatic breast cancer patients after sequential immune-endocrine therapy

Figure 3

Clinical exam photographs, imaging (PET/CT), tumor marker (CA 27-29) and treatment regimens according to timeline for patient 2. At initial presentation of the patient in August 2009, the locally advanced breast cancer involved the overlying skin, axillary lymph nodes and invaded the pectoralis muscle. In addition an adrenal metastasis and mediastinal lymph nodes were detected by imaging. Interval treatments included paclitaxel, trastuzumab, LH-RH agonist, tamoxifen, topical imiquimod followed by fulvestrant, on which the patient experienced a complete response including breast, lymph nodes and adrenal lesions in October of 2011. At last follow up May 2014, patient had no clinical or radiographic evidence of disease.

Back to article page